Assessing patient characteristics and radiation-induced non-targeted effects in vivo for high dose-rate (HDR) brachytherapy

References

• Ahmad SB, McNeill FE, Byun SH, Prestwich WV, Mothersill C, Seymour C, Armstrong A, Fernandez C. 2013. Ultra-violet light emission from HPV-G cells irradiated with low let radiation from (90)Y; consequences for radiation induced bystander effects. Dose-Response 11:498:–Res
   PubMed Web of Science ®Google Scholar
• Berry B, Miller RR, Luoma A, Nelems B, Hay J, Flores AD. 1989. Pathologic findings in total esophagectomy specimens after intracavitary and external-beam radiotherapy. Cancer 64:1833–1837.
   PubMed Web of Science ®Google Scholar
• Boyden S, Raaphorst GP. 1999. Adaptive response and its variation in human normal and tumour cells. Int J Radiat Biol 75:865–873.
   PubMed Web of Science ®Google Scholar
• Boyd M, Sorensen A, McCluskey AG, Mairs RJ. 2008. Radiation quality-dependent bystander effects elicited by targeted radionuclides. J Pharm Pharmacol 60:951–958.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Curtis RE, Hall EJ, Ron E. 2000. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88:398–406.
   PubMed Web of Science ®Google Scholar
• Butterworth KT, McMahon SJ, Hounsell AR, O’Sullivan JM, Prise KM. 2013. Bystander signalling: Exploring clinical relevance through new approaches and new models. Clin Oncol 25:586–592.
   PubMed Web of Science ®Google Scholar
• Chai Y, Hei TK. 2008. Radiation induced bystander effect in vivo. Acta Med Nagasaki 53:S65–S69.
   PubMedGoogle Scholar
• Chiou CC, Groll AH, Walsh TJ. 2000. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 5:120–135.
   PubMedGoogle Scholar
• Delsing CE, Bleeker-Rovers CP, van de Veerdonk FL, Tol J, Van der Meer JWM, Kullberg BJ, Netea MG. 2012. Association of esophageal candidiasis and squamous cell carcinoma. Med Mycol 1:5–8.
   Google Scholar
• Emerit I, Levy A, Cernjavski L, Arutyunyan R, Oganesyan N, Pogosian A, Mejlumian H, Sarkisian T, Gulkandanian M, Quastel M. 1994. Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor. J Cancer Res Clin Oncol 120:558–561.
   PubMed Web of Science ®Google Scholar
• Emerit I, Oganesian N, Sarkisian T, Arutyunyan R, Pogosian A, Asrian K, Levy A, Cernjavski L. 1995. Clastogenic factors in the plasma of Chernobyl accident recovery workers: Anticlastogenic effect of Ginkgo biloba extract. Radiat Res 144:198–205.
   PubMed Web of Science ®Google Scholar
• Emerit I, Quastel M, Goldsmith J, Merkin L, Levy A, Cernjavski L, Alaoui-Youssefi A, Pogossian A, Riklis E. 1997. Clastogenic factors in the plasma of children exposed at Chernobyl. Mutat Res 373: 47–54.
   PubMed Web of Science ®Google Scholar
• Faguet GB, Reichard SM, Welter DA. 1984. Radiation-induced clastogenic plasma factors. Cancer Genet Cytogenet 12:73–83.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191.
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Bryant SM, DiZerega GS. 1988. Superoxide anion production by postsurgical macrophages. J Surg Res 45:382–388.
   PubMed Web of Science ®Google Scholar
• Goh K, Sumner H. 1968. Breaks in normal human chromosomes: Are they induced by a transferable substance in the plasma of persons exposed to total-body irradiation? Radiat Res 35:171–181.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Wuu CS. 2003. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83–88.
   PubMed Web of Science ®Google Scholar
• Hollowell JG Jr, Littlefield LG. 1968. Chromosome damage induced by plasma of x-rayed patients: An indirect effect of x-ray. Proc Soc Exp Biol Med 129:240–244.
   PubMed Web of Science ®Google Scholar
• Howe O, O’Sullivan J, Nolan B, Vaughan J, Gorman S, Clarke C, McClean B, Lyng FM. 2009. Do radiation-induced bystander effects correlate to the intrinsic radiosensitivity of individuals and have clinical significance? Radiat Res 171:521–529.
   PubMed Web of Science ®Google Scholar
• Johnston JR, Godzik C, Cohn Z. 1978. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med 148:115–129.
   PubMed Web of Science ®Google Scholar
• Koturbash I, Kutanzi K, Hendrickson K, Rodriguez-Juarez R, Kogosov D, Kovalchuk O. 2008. Radiation-induced bystander effects in vivo are sex specific. Mutat Res 642:28–36.
   PubMed Web of Science ®Google Scholar
• Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. 2001. Inflammatory-type responses after exposure to ionizing radiation in vivo: A mechanism for radiation-induced bystander effects? Oncogene 20:7085–7095.
   PubMed Web of Science ®Google Scholar
• Lyng FM, Maguire P, McClean B, Seymour C, Mothersill C. 2006. The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects. Radiat Res 165:4005:at.
   Web of Science ®Google Scholar
• Lyng FM, Seymour CB, Mothersill C. 2000. Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis. Br J Cancer 83:1223–1230.
   PubMed Web of Science ®Google Scholar
• Maguire P, Mothersill C, McClean B, Seymour CB, Lyng FM. 2007. Modulation of radiation responses by pre-exposure to irradiated cell conditioned medium. Radiat Res 167:485–492.
   PubMed Web of Science ®Google Scholar
• Manda K., Glasow A, Paape D, Hildebrandt G. 2012. Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells. Front Oncol 2:102.
   PubMedGoogle Scholar
• Marozik P, Mothersill C, Seymour CB, Mosse I, Melnov S. 2007. Bystander effects induced by serum from survivors of the Chernobyl accident. Exp Hematol 35:55–63.
   PubMed Web of Science ®Google Scholar
• Michiels C. 2004. Physiological and pathological responses to hypoxia. Am J Pathol 164:1875–1882.
   PubMed Web of Science ®Google Scholar
• Mitchell JB, Bedford JS, Bailey SM. 1979. Dose-rate effects in plateau-phase cultures of S3 HeLa and V79 cells. Radiat Res 79:552–567.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Taghavi-Dehaghani M, Gharaati MR, Masoomi R, Ghiassi-Nejad M. 2006. Adaptive response of blood lymphocytes of inhabitants residing in high background radiation areas of ramsar- micronuclei, apoptosis and comet assays. J Radiat Res 47:279–285.
   PubMed Web of Science ®Google Scholar
• Morgan WF. 2003. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 159:581–596.
   PubMed Web of Science ®Google Scholar
• Mothersill C. 2013. Uncomfortable issues in radiation protection posed by low-dose radiobiology. Radiat Environ Biophys 52:293–298.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Moriarty M, Seymour C. 2004a. Radiotherapy and the potential exploitation of bystander effects. Int J Radiat Oncol Biol Phys 58:575–579.
   PubMed Web of Science ®Google Scholar
• Mothersill C, O’Malley K, Seymour CB. 2002. Characterisation of a bystander effect induced in human tissue explant cultures by low LET radiation. Radiat Prot Dosimetry 99:163–167.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Rea D, Wright EG, Lorimore SA, Murphy D, Seymour CB, O’Malley K. 2001. Individual variation in the production of a ‘bystander signal’ following irradiation of primary cultures of normal human urothelium. Carcinogenesis 22:1465cinog
   Web of Science ®Google Scholar
• Mothersill C, Seymour CB. 2006. Radiation-induced bystander and other non-targeted effects: Novel intervention points in cancer therapy? Curr Cancer Drug Targets 6:447–454.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Seymour C. 1997. Survival of human epithelial cells irradiated with cobalt 60 as microcolonies or single cells. Int J Radiat Biol 72:597–606.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Seymour CB. 2004. Radiation-induced bystander effects – implications for cancer. Nat Rev Cancer 4:158–164.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Seymour RJ, Seymour CB. 2004b. Bystander effects in repair-deficient cell lines. Radiat Res 161:256–263.
   PubMed Web of Science ®Google Scholar
• Multhoff G, Radons J. 2012. Radiation, inflammation, and immune responses in cancer. Front Oncol 2:58.
   PubMedGoogle Scholar
• O’Dowd C, Mothersill CE, Cairns MT, Austin B, McClean B, Lyng FM, Murphy JEJ. 2006. The release of bystander factor(s) from tissue explant cultures of rainbow trout (Onchorhynchus mykiss) after exposure to gamma radiation. Radiat Res 166:611–617.
   PubMed Web of Science ®Google Scholar
• Pant GS, Kamada N. 1977. Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals. Hiroshima J Med Sci 26:149–154.
   PubMed Web of Science ®Google Scholar
• Pinho C, Wong R, Sur RK, Hayward JE, Farrell TJ, Seymour C, Mothersill C. 2012. The involvement of serum serotonin levels producing radiation-induced bystander effects for an in vivo assay with fractionated high dose-rate (HDR) brachytherapy. Int J Radiat Biol 88:791–797.
   PubMed Web of Science ®Google Scholar
• Pirisi L, Creek KE, Doniger J, Dipaolo JA. 1988. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 9:1573–1579.
   PubMed Web of Science ®Google Scholar
• Prise KM, Belyakov OV, Folkard M, Michael BD. 1998. Studies of bystander effects in human fibroblasts using a charged particle microbeam. Int J Radiat Biol 74:793–798.
   PubMed Web of Science ®Google Scholar
• Prise KM, O’Sullivan JM. 2009. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 9:351–360.
   PubMed Web of Science ®Google Scholar
• Qutob SS, Multani AS, Pathak S, McNamee JP, Bellier PV, Liu QY, Ng CE. 2006. Fractionated X-radiation treatment can elicit an inducible-like radioprotective response that is not dependent on the intrinsic cellular X-radiation resistance/sensitivity. Radiat Res 166:590–599.
   PubMed Web of Science ®Google Scholar
• Rödel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schöllnberger H, Hildebrandt G, Rödel C. 2012. Modulation of inflammatory immune reactions by low-dose ionizing radiation: Molecular mechanisms and clinical application. Curr Med Chem 19:1741–1750.
   PubMed Web of Science ®Google Scholar
• Ryan LA, Seymour CB, Joiner MC, Mothersill CE. 2009. Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response. Int J Radiat Biol 85:87–95.
   PubMed Web of Science ®Google Scholar
• Ryan LA, Smith RW, Seymour CB, Mothersill CE. 2008. Dilution of irradiated cell conditioned medium and the bystander effect. Radiat Res 169:188iat R
   PubMed Web of Science ®Google Scholar
• Seymour CB, Mothersill C. 2000. Relative contribution of bystander and targeted cell killing to the low-dose region of the radiation dose-response curve. Radiat Res 153:508–511.
   PubMed Web of Science ®Google Scholar
• Seymour C, Mothersill C. 2006. Development of an in vivo assay for detection of non-targeted radiation effects. Dose Response 4:277–282.
   PubMedGoogle Scholar
• Sur RK, Donde B, Levin VC, Mannell A. 1998. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 40:447–453.
   PubMed Web of Science ®Google Scholar
• Sur RK, Levin CV, Donde B, Sharma V. Miszczyk L, Nag S. 2002. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma–an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 53: 127–133.
   PubMed Web of Science ®Google Scholar
• Thomas C, Martin J, Devic C, Bräuer-Krisch E, Diserbo M, Thariat J, Foray N. 2013. Impact of dose-rate on the low-dose hyper-radiosensitivity and induced radioresistance (HRS/IRR) response. Int J Radiat Biol 89:813–822.
   PubMed Web of Science ®Google Scholar
• Twardella D, Chang-Claude J. 2002. Studies on radiosensitivity from an epidemiological point of view – overview of methods and results. Radiother Oncol 62:249–260.
   PubMed Web of Science ®Google Scholar
• Yoshioka Y, Yoshida K, Yamazaki H, Nonomura N, Ogawa K. 2013. The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer. J Radiat Res 54:781–788.
   PubMed Web of Science ®Google Scholar